Added Predictive Ability of the CHA 2 DS 2 VASc Risk Score for Stroke and Death in Patients With Atrial Fibrillation
- 1 May 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 5 (3) , 335-342
Abstract
Background—: The objective of this study was to evaluate the added predictive ability of the CHA 2 DS 2 VASc prediction rule for stroke and death in a nonanticoagulated population of patients with atrial fibrillation. Methods and Results—: We included 1603 nonanticoagulated patients with incident atrial fibrillation from a Danish prospective cohort study of 57 053 middle-aged men and women. The Net Reclassification Improvement was calculated as a measure to estimate any overall improvement in reclassification with the CHA 2 DS 2 VASc sore as an alternative to the CHADS 2 score. After 1-year follow-up, crude incidence rates were 3.4 per 100 person-years for stroke and 13.6 for death. After a mean follow-up of 5.4 years (±3.7 years), the crude incidence rates for stroke and death were 1.9 and 5.6, respectively. During the entire observation period, the c-statistics and negative predictive values were similar for both risk scores. The Net Reclassification Improvement analysis showed that 1 of 10 reclassified atrial fibrillation patients would have been upgraded correctly using the CHA 2 DS 2 VASc score. Conclusions—: Both the CHADS 2 as well as the CHA 2 DS 2 VASc risk score can exclude a large proportion of patients from having high risk of stroke or death. However, using the CHA 2 DS 2 VASc risk score, fewer patients will fulfill the criterion for low risk (and are truly low risk for thromboembolism). For every 10 extra patients transferred to the treatment group at 5 years, using the CHA 2 DS 2 VASc risk score, 1 patient would have had a stroke that might have been avoided with effective treatment.Keywords
This publication has 21 references indexed in Scilit:
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort studyBMJ, 2011
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest, 2010
- The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?Thrombosis and Haemostasis, 2010
- Atrial fibrillation and stroke preventionThe Lancet Neurology, 2007
- Independent predictors of stroke in patients with atrial fibrillationNeurology, 2007
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive SummaryJACC, 2006
- Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial FibrillationCirculation, 2005
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001